{"id":180273,"date":"2018-01-24T08:49:03","date_gmt":"2018-01-24T08:49:03","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=180273"},"modified":"2018-01-24T08:49:03","modified_gmt":"2018-01-24T08:49:03","slug":"world-soft-tissue-sarcoma-market-2018-competitive-analysis-solid-segments-top-players-revenue-and-forecasts-till-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/world-soft-tissue-sarcoma-market-2018-competitive-analysis-solid-segments-top-players-revenue-and-forecasts-till-2023_180273.html","title":{"rendered":"World Soft Tissue Sarcoma Market 2018 Competitive Analysis | Solid Segments | Top Players Revenue and Forecasts Till 2023"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Soft Tissue Sarcoma Market”<\/div>\n<\/div>\n<\/div>\n
The Global Soft Tissue Sarcoma Market report consists of regions namely the Americas, Europe, Asia Pacific, and the Middle East and Africa. The soft tissue sarcoma industry is segmented on the basis of treatment, disease type, distribution channel, and end-users.<\/div>\n

The Global Soft Tissue Sarcoma Market is expected to grow at a CAGR of approximately 8.2% during the forecast period 2017-2023. Soft tissue sarcoma is a type of cancer that develops from tissues such as nerves, muscles, fats, blood vessels and deep skin tissues. Generally <\/span><\/span>Soft Tissue Sarcoma Market<\/a><\/span><\/span> report explores the occurring in the muscles, tissues, and blood vessels that protect, support and surround the organs. Moreover, it is not categorized as tumor, but can be life-threatening if the cancer spreads to other parts of the body. There are around 50 different types of soft tissue sarcoma, such as adult fibrosarcoma, angiosarcoma, clear cell sarcoma, alveolar soft-part sarcoma, kaposi sarcoma, malignant mesenchymoma, rhabdomyosarcoma, and others.<\/span><\/span><\/em><\/p>\n

Currently, there are very few products approved for the treatment of soft tissue sarcoma. For instance, in October 2016, U.S. Food and Drug Administration issued an accelerated approval notice for Eli Lilly and Company’s drug Lartruvo (Olaratumab) with Doxorubicin to treat certain type’s soft tissue carcinoma. Some of the drugs used for the treatment of soft tissue sarcoma include trabectedin (yondelis), sunitinib (sutent), sirolimus (rapamune), and doxorubicin (adriamycin), bevacizumab (avastin), and others.<\/span><\/span><\/em><\/p>\n

Increase in the incidence and prevalence of different types of cancers, rising cases of soft tissue sarcoma, increasing R&D activities on drugs and other therapies, patent expiry of branded drugs, are some of the factors fuelling the growth of the soft tissue sarcoma market over the forecast period. However, stringent regulatory guidelines, adverse side effects of the treatment, and high cost for the radiotherapy and chemotherapy may hinder the growth of soft tissue sarcoma treatment market over the forecast period.<\/span><\/span><\/em><\/p>\n

Premium Sample Copy @ <\/span><\/span>https:\/\/www.marketresearchfuture.com\/sample_request\/5304<\/a> .<\/span><\/span><\/em><\/p>\n

The methods for diagnosis of soft tissue sarcoma include some physical examination such as X-ray imaging, CT scan, MRI, ultrasound, PET scan and a biopsy. Such examinations in conjugation with other tests are important to plan a suitable treatment method for this condition.<\/span><\/span><\/em><\/p>\n

Soft Tissue Sarcoma Market Key Players:<\/span><\/span><\/em><\/p>\n

Some of key the players in the global soft tissue sarcoma market are GlaxoSmithKline plc (U.K), Eli Lilly and Company (U.S.), Pfizer, Inc. (U.S.), Bristol-Myers Squibb (U.S.), F. Hoffmann-La Roche AG (Genentech) (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Teva Pharmaceutical Industries Ltd (Israel), and Celgene Corporation (U.S.) and others.<\/span><\/span><\/em><\/p>\n

Various key players are active in the soft tissue sarcoma treatment market in terms of product launches, research, and development activities. For instance, in 2012, Threshold Pharmaceuticals Inc. signed a global license agreement for Evofosfamide, which is the most advanced first-line drug for soft tissue sarcoma with Merck KGaA. GSK’s Votrient (pazopanib) is approved for second-line treatment, and another drug Aldoxorubicin is approved as first-line drug for the treatment of soft tissue sarcoma. Currently, doxorubicin is commonly used for the treatment of soft tissue sarcoma<\/span><\/span><\/em><\/p>\n

Soft Tissue Sarcoma Market Segmentation:<\/span><\/span><\/em><\/p>\n

The soft tissue sarcoma is segmented on the basis of treatment, disease type, distribution channel, and end-users. <\/span><\/span><\/em><\/p>\n

On the basis of the treatment type, the soft tissue sarcoma treatment market is segmented into targeted therapy, chemotherapy, anti-angiogenesis drugs, radiation therapy. Furthermore, the radiation therapy is subcatergorized into internal radiation therapy and external radiation therapy.<\/span><\/span><\/em><\/p>\n

On the basis of the disease type, soft tissue sarcoma treatment market is segmented into local sarcoma, regional sarcoma, and metastatic sarcoma<\/span><\/span><\/em><\/p>\n

On the basis of the distribution channel, soft tissue sarcoma treatment market is segmented into hospital pharmacies, retail pharmacies and others.<\/span><\/span><\/em><\/p>\n

On the basis of the end user, the global soft tissue sarcoma treatment market has been segmented into hospitals, oncology centers, and long term care centers.<\/span><\/span><\/em><\/p>\n

Get Discount @<\/span><\/span> https:\/\/www.marketresearchfuture.com\/check-discount\/5304<\/a> .<\/span><\/span><\/em><\/p>\n

Table of Content for Soft Tissue Sarcoma Market:<\/span><\/span><\/em><\/p>\n

Chapter 1.        Report Prologue <\/span><\/span><\/em><\/p>\n

Chapter 2.        Market Introduction <\/span><\/span><\/em><\/p>\n

2.1        Definition  <\/span><\/span><\/em><\/p>\n

2.2        Scope of the Study <\/span><\/span><\/em><\/p>\n

2.2.1     Research Objective   <\/span><\/span><\/em><\/p>\n

2.2.2     Assumptions    <\/span><\/span><\/em><\/p>\n

2.2.3     Limitations       <\/span><\/span><\/em><\/p>\n

Chapter 3.        Research Methodology<\/span><\/span><\/em><\/p>\n

3.1        Introduction<\/span><\/span><\/em><\/p>\n

3.2        Primary Research         <\/span><\/span><\/em><\/p>\n

3.3        Secondary research      <\/span><\/span><\/em><\/p>\n

3.4        Market Size Estimation<\/span><\/span><\/em><\/p>\n

Chapter 4.        Market Dynamics<\/span><\/span><\/em><\/p>\n

4.1        Drivers <\/span><\/span><\/em><\/p>\n

4.2        Restrains<\/span><\/span><\/em><\/p>\n

4.3        Opportunities   <\/span><\/span><\/em><\/p>\n

4.4        Challenges<\/span><\/span><\/em><\/p>\n

4.5        Macroeconomic Indicators<\/span><\/span><\/em><\/p>\n

4.6        Technology Trends & Assessment                                <\/span><\/span><\/em><\/p>\n

Chapter 5.        Market Factor Analysis<\/span><\/span><\/em><\/p>\n

5.1        Porter’s Five Forces Analysis<\/span><\/span><\/em><\/p>\n

5.1.1     Bargaining Power of Suppliers  <\/span><\/span><\/em><\/p>\n

5.1.2     Bargaining Power of Buyers<\/span><\/span><\/em><\/p>\n

5.1.3     Threat of New Entrants <\/span><\/span><\/em><\/p>\n

5.1.4     Threat of Substitutes    <\/span><\/span><\/em><\/p>\n

5.1.5     Intensity of Rivalry        <\/span><\/span><\/em><\/p>\n

5.2        Value Chain Analysis<\/span><\/span><\/em><\/p>\n

5.3        Investment Feasibility Analysis  <\/span><\/span><\/em><\/p>\n

5.4        Pricing Analysis<\/span><\/span><\/em><\/p>\n

…TOC Continued<\/span><\/span><\/em><\/p>\n

Ask Questions To Expertise @ <\/span><\/span>https:\/\/www.marketresearchfuture.com\/enquiry\/5304<\/a> .<\/span><\/span><\/em><\/p>\n

About US:<\/span><\/span><\/em><\/strong><\/p>\n

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.<\/span><\/span><\/em><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Market Research Future
Contact Person:<\/strong> Akash Anand
Email:<\/strong> akash.anand@marketresearchfuture.com
Phone:<\/strong> +1 646 845 9312
Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> https:\/\/www.marketresearchfuture.com\/sample_request\/5304<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Soft Tissue Sarcoma Market” The Global Soft Tissue Sarcoma Market report consists of regions namely the Americas, Europe, Asia Pacific, and the Middle East and Africa. The soft tissue sarcoma industry is segmented on the basis of treatment, disease type, … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-180273","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/180273","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=180273"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/180273\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=180273"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=180273"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=180273"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}